– Reuters
Why Viking Therapeutics Stock Is Soaring Tuesday
Viking Therapeutics Inc (NASDAQ: VKTX) shares are trading higher Tuesday after the company reported results from its Phase 1 trial of VK2735 for the potential treatment of
Related Posts
Schlumberger’s Strategic Expansion Pays Off: Surpasses Q1 Topline Expectations, Commits To $7B Shareholder Return
Schlumberger reported a first-quarter 2024 revenue increase of 13% year-over-year to $8.707 billion, beating the consensus of $8.689 billion. Adjusted EPS increased 19% Y/Y to $0.75, which aligned with the consensus.
Lucid Group Misses On Q1 Earnings: Shares Fall On Revenue, EPS Miss, EV Manufacturer Gives Update On Production, Upcoming Gravity SUV
Electric vehicle company Lucid Group (NASDAQ: LCID) reported first-quarter financial results after the market close Monday. Here are the key highlights.
Is Shiba Inu About To Get Dethroned? The Rise Of PEPE Coin
The recent surge of PEPE (CRYPTO: PEPE) has market observers buzzing in the wacky world of memecoins.